Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (461-470 of 548) with videos related to

Pageof 55
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.
Neuroreport|October 3, 1994
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazoleG M MacKenzie, S Rose, P A Bland-Ward, et al.
European Journal of Pharmacology|April 24, 1995
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmosetK K Gnanalingham, N A Milkowski, L A Smith, et al.
Journal of Neural Transmission|January 1, 1985
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugsN M Rupniak, M D Hall, E Kelly, et al.
Neuropharmacology|October 1, 1989
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinA Ueki, P N Chong, A Albanese, et al.
European Journal of Pharmacology|March 3, 1992
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsK W Lange, P A Löschmann, H Wachtel, et al.
Biochemical Pharmacology|December 1, 1987
Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?B Testa, P Jenner, G J Kilpatrick, et al.
Brain Research|January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in manR Raisman-Vozari, J A Girault, S Moussaoui, et al.
Brain Research|December 16, 1996
Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antiseraA G Riedl, P M Watts, R J Edwards, et al.
Pageof 55

Showing results (461-470 of 548) with videos related to

Sort By:
Pageof 55
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.
Neuroreport|October 3, 1994
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazoleG M MacKenzie, S Rose, P A Bland-Ward, et al.
European Journal of Pharmacology|April 24, 1995
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmosetK K Gnanalingham, N A Milkowski, L A Smith, et al.
Journal of Neural Transmission|January 1, 1985
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugsN M Rupniak, M D Hall, E Kelly, et al.
Neuropharmacology|October 1, 1989
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinA Ueki, P N Chong, A Albanese, et al.
European Journal of Pharmacology|March 3, 1992
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsK W Lange, P A Löschmann, H Wachtel, et al.
Biochemical Pharmacology|December 1, 1987
Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?B Testa, P Jenner, G J Kilpatrick, et al.
Brain Research|January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in manR Raisman-Vozari, J A Girault, S Moussaoui, et al.
Brain Research|December 16, 1996
Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antiseraA G Riedl, P M Watts, R J Edwards, et al.
Pageof 55